Anagrelide (anagrelide): Reviews and patient testimonials
Back to the list of medications
Medication indications
Anagrelide 0.5 mg hard capsules
Anagrelide is indicated for the reduction of elevated platelet counts in at risk essential thrombocythaemia (ET) patients who are intolerant to their current therapy or whose elevated platelet counts are not reduced to an acceptable level by their current therapy.
An at risk patient
An at risk essential thrombocythaemia patient is defined by one or more of the following features:
• >60 years of age or
• a platelet count > 1000 x 109/l or
• a history of thrombo-haemorrhagic events.
Anagrelide Zentiva 0.5 mg hard capsules
Anagrelide is indicated for the reduction of elevated platelet counts in at risk essential thrombocythaemia (ET) patients who are intolerant to their current therapy or whose elevated platelet counts are not reduced to an acceptable level by their current therapy.
An at risk patient
An at risk essential thrombocythaemia patient is defined by one or more of the following features:
• >60 years of age or
• a platelet count > 1000 x 109/l or
• a history of thrombo-haemorrhagic events.
Route of administration: Oral
Molecule: anagrelide
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.